Business Wire - Research and Markets: New Report Predicts that Novartis’ Diovan, Glivec/Gleevec and Zelmac/Zelnorm will Continue to Show Healthy Sales Growth
Tuesday, November 11th, 2008 DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/reports/c64756) has announced the addition of Novartis: Performance, Products, Pipeline and Potential to their offering.
Pharmaceutical company intelligence reports provide a ful…
